HIV envelope tail truncation confers resistance to SERINC5 restriction

Proc Natl Acad Sci U S A. 2021 May 25;118(21):e2101450118. doi: 10.1073/pnas.2101450118.

Abstract

SERINC5 is a potent lentiviral restriction factor that gets incorporated into nascent virions and inhibits viral fusion and infectivity. The envelope glycoprotein (Env) is a key determinant for SERINC restriction, but many aspects of this relationship remain incompletely understood, and the mechanism of SERINC5 restriction remains unresolved. Here, we have used mutants of HIV-1 and HIV-2 to show that truncation of the Env cytoplasmic tail (ΔCT) confers complete resistance of both viruses to SERINC5 and SERINC3 restriction. Critically, fusion of HIV-1 ΔCT virus was not inhibited by SERINC5 incorporation into virions, providing a mechanism to explain how EnvCT truncation allows escape from restriction. Neutralization and inhibitor assays showed ΔCT viruses have an altered Env conformation and fusion kinetics, suggesting that EnvCT truncation dysregulates the processivity of entry, in turn allowing Env to escape targeting by SERINC5. Furthermore, HIV-1 and HIV-2 ΔCT viruses were also resistant to IFITMs, another entry-targeting family of restriction factors. Notably, while the EnvCT is essential for Env incorporation into HIV-1 virions and spreading infection in T cells, HIV-2 does not require the EnvCT. Here, we reveal a mechanism by which human lentiviruses can evade two potent Env-targeting restriction factors but show key differences in the capacity of HIV-1 and HIV-2 to exploit this. Taken together, this study provides insights into the interplay between HIV and entry-targeting restriction factors, revealing viral plasticity toward mechanisms of escape and a key role for the long lentiviral EnvCT in regulating these processes.

Keywords: Env; HIV; IFITM; SERINC; restriction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Differentiation / genetics
  • Antigens, Differentiation / immunology
  • Cell Line
  • Gene Expression Regulation
  • HEK293 Cells
  • HIV Infections / genetics
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • HIV-1 / pathogenicity
  • HIV-2 / genetics*
  • HIV-2 / immunology
  • HIV-2 / pathogenicity
  • HeLa Cells
  • Humans
  • Immune Evasion
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / immunology
  • Membrane Proteins / genetics*
  • Membrane Proteins / immunology
  • Protein Domains
  • Protein Isoforms / genetics
  • Protein Isoforms / immunology
  • Signal Transduction
  • Stem Cells
  • Virion / genetics*
  • Virion / immunology
  • Virion / pathogenicity
  • Virus Internalization
  • env Gene Products, Human Immunodeficiency Virus / genetics*
  • env Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • Antigens, Differentiation
  • Membrane Glycoproteins
  • Membrane Proteins
  • Protein Isoforms
  • SERINC3 protein, human
  • SERINC5 protein, human
  • env Gene Products, Human Immunodeficiency Virus
  • leu-13 antigen